ViroCyt, Inc.

Exhibitor

ViroCyt LLC was spun out of InDevR, Inc. in late 2012 to focus on the commercialization of novel technologies – such as the Virus Counter 2100 – that enable rapid quantification of viruses. Our goal is to provide the tools that deliver meaningful improvements to mission critical processes, such as vaccine manufacturing, protein expression, antiviral development and other settings where viruses play a significant role.

website